HKBU Develops Chinese Medicine for Ulcerative Colitis Approved by National Medical Products Administration for Clinical Trial

The Centre for Chinese Herbal Medicine Drug Development (CDD) at Hong Kong Baptist University (HKBU) has achieved a significant milestone in developing a novel Chinese herbal formulation for ulcerative colitis remission maintenance.